Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01506960 · ClinicalTrials.gov registry record · Phase 4
Evaluation of a Combined Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Catheter for Detection of Lipid Rich Plaque
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT01506960: Clinical Trial Phase 4 study, sponsored by Massachusetts General Hospital.
NCT01506960 is a Phase 4 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01506960, a Phase 4 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about lipid rich plaque using Near Infrared Spectroscopy (NIRS)/Intravascular Ultrasound (IVUS) imaging in patients who have had coronary artery stenting and Optical coherence tomography (OCT) imaging.
Interventions
- DEVICE InfraReDx Lipiscan IVUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01506960
The ClinicalTrials.gov registry entry for NCT01506960 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which InfraReDx Lipiscan IVUS is the first listed.
NCT01506960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01506960 about?
NCT01506960 is a clinical study titled "Evaluation of a Combined Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Catheter for Detection of Lipid Rich Plaque". The purpose of this study is to learn more about lipid rich plaque using Near Infrared Spectroscopy (NIRS)/Intravascular Ultrasound (IVUS) imaging in patients who have had coronary artery stenting and Optical coherence tomography (OCT) imaging.
What is the current status of trial NCT01506960?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2012-01. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01506960?
The interventions under investigation include: InfraReDx Lipiscan IVUS (DEVICE).
Who is sponsoring clinical trial NCT01506960?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.